Platinum Sponsors
AstraZeneca
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients.
- www.astrazeneca.com
- Booth no. 7
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
- www.novartis.com
- Booth no. 2
Gold Sponsors
BMS
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.
Roche
Our ultimate vision is to prevent and provide cures for cancer in all its forms. As no single intervention is likely to achieve this, we seek to comprehensively understand the disease, its complexities and its impact on patients. Our focus thus lies in pushing for progress in cancer prevention, increasing disease awareness, developing innovative screening and diagnostic technologies, and advancing our understanding of the disease and its causes.
- www.roche.com
- Booth no. 6
Silver Sponsor
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.
Supporters
AMGEN
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases. We discover, develop, manufacture and deliver innovative medicines to help millions of patients. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Pfizer, Inc.
Pfizer Oncology is at the forefront of a new era in cancer care. Driven by science, we are committed to accelerating breakthroughs to help people with cancer live better and longer lives.
Exhibitors
MedChemExpress
MedChemExpress is a global supplier of chemical and biochemical reagents, offering a wide range of compounds for research in medicine, pharmacy, and biology. We are committed to supporting scientists with high-quality products and diverse compound libraries. Our dedicated sales team in France and across Europe ensures exceptional customer service, contributing to advancements in scientific research.
- www.medchemexpress.com
- Booth no. 5
Oncolines B.V.
Oncolines B.V., is a precision medicine services company in oncology and cancer immunotherapy. We offer services to enable our clients to determine the activity, selectivity and mechanism of action of drug candidates. Our platforms comprise cancer cell panel profiling, drug combination testing, bioinformatics, flow cytometry, sequencing, generation of drug resistant cell lines, biochemical assays and target residence time measurement.
- www.oncolines.com
- Booth no. 4
Resilience
Resilience is a comprehensive Remote Patient Care solution dedicated to cancer patients and healthcare professionals. Combining a mobile application with Remote Patient Monitoring platform (class IIa medical device), Resilience ensures better care by personalizing, humanizing, and improving the care pathway. The company partners with more than 100 centers and supports over 10,000 patients.
- www.resilience.care
- Booth no. 3
Educational Grant
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
L’Institut Servier
L’Institut Servier is a non-profit association under French law. It aims to perpetuate the values of the Servier Group through a desire to develop research in all its forms and contribute to medical knowledge for patient well-being.